Scrip
2010 Scrip 100 - Infectious disease trials analysis
09 December 2009
Karen Currie
Please Login to read the full article.
09 December 2009
Karen Currie
disease analysis
The largest number of new trial starts captured within the infectious disease portfolio in TrialTrove for the period September 1st, 2008, to August 31st, 2009 was in vaccine development. Influenza vaccines – seasonal and pandemic – accounted for more than half of all vaccine...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Japan to subsidise Takeda's cell cultured flu vaccine R&D
- Merck's boceprevir improves cure rates in two pivotal hepatitis C trials
- Merck pipeline update: ESA development ditched because of regulatory hurdles
- Novartis building Chinese presence with vaccines acquisition and R&D investment
FEATURES
- Connexios: Harnessing the Indian cost advantage in network biology
- Face-to-Face: Trophos - The French firm that hooked Actelion
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
